Literature DB >> 23506790

A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome.

Stephen R Hooper1, Kathleen Curtiss, Kelly Schoch, Matcheri S Keshavan, Andrew Allen, Vandana Shashi.   

Abstract

The present study sought to examine the longitudinal psychoeducational, neurocognitive, and psychiatric outcomes of children and adolescents with chromosome 22q11.2 deletion syndrome (22q11DS), a population with a high incidence of major psychiatric illnesses appearing in late adolescence/early adulthood. Little is known of the developmental changes that occur in the early teen years, prior to the age of highest psychosis risk. Data were collected from 71 participants (42 subjects with 22q11DS and 29 control subjects) at Time 1 (T1) and Time 2 (T2), approximately 3.5 years later. The 22q11DS group was significantly lower functioning than controls on IQ, neurocognition, and academic achievement at both T1 and T2. Children with 22q11DS also showed significantly greater social-behavioral difficulties and psychiatric symptoms, and were more likely to meet criteria for psychiatric disorders at both time points. In evaluating change over time from T1 to T2, the 22q11DS group did not show significant changes in psychoeducational or psychiatric outcomes relative to the controls, however, lack of expected age-related gains in attention regulation were noted. Within the 22q11DS group, an increase in the Attenuated Prodrome for Schizophrenia (number of psychiatric symptoms) was noted from T1 to T2 and four children with 22q11DS met criteria for Psychosis for the first time. Predictors at T1 that uncovered psychopathology symptoms at T2 included full-scale IQ, externalizing symptoms, and problem social behaviors. Overall, younger adolescent and preadolescent children with 22q11DS in this study exhibited slowed growth in attention regulation, with an increase in subclinical symptoms of schizophrenia, suggestive of increasing impairments in domains that are relevant to the high risk of Schizophrenia. Early predictors of later psychopathology included both cognitive and behavioral abnormalities. These findings begin to elucidate the trajectory of changes in psychopathology in children with 22q11DS in the years leading up to the onset of major psychiatric illnesses.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23506790      PMCID: PMC3783943          DOI: 10.1016/j.ridd.2012.12.003

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  34 in total

1.  NIMH-MATRICS survey on assessment of neurocognition in schizophrenia.

Authors:  Robert S Kern; Michael F Green; Keith H Nuechterlein; Bi-Hong Deng
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

2.  The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families.

Authors:  B A Cornblatt; N J Risch; G Faris; D Friedman; L Erlenmeyer-Kimling
Journal:  Psychiatry Res       Date:  1988-11       Impact factor: 3.222

3.  Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives.

Authors:  A E Pulver; G Nestadt; R Goldberg; R J Shprintzen; M Lamacz; P S Wolyniec; B Morrow; M Karayiorgou; S E Antonarakis; D Housman
Journal:  J Nerv Ment Dis       Date:  1994-08       Impact factor: 2.254

4.  Schizophrenic-like neurocognitive deficits in children and adolescents with 22q11 deletion syndrome.

Authors:  Kathryn Eve Lewandowski; Vandana Shashi; Peggy M Berry; Thomas R Kwapil
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-01-05       Impact factor: 3.568

Review 5.  Velo-cardio-facial syndrome: a distinctive behavioral phenotype.

Authors:  R J Shprintzen
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2000

6.  Mapping cortical morphology in youth with velocardiofacial (22q11.2 deletion) syndrome.

Authors:  Wendy R Kates; Ravi Bansal; Wanda Fremont; Kevin M Antshel; Xuejun Hao; Anne Marie Higgins; Jun Liu; Robert J Shprintzen; Bradley S Peterson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-01-14       Impact factor: 8.829

7.  Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?

Authors:  D F Papolos; G L Faedda; S Veit; R Goldberg; B Morrow; R Kucherlapati; R J Shprintzen
Journal:  Am J Psychiatry       Date:  1996-12       Impact factor: 18.112

8.  COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Stephan Eliez; Tracy Thompson; Christine Hinard; Lauren Penniman; Carl Feinstein; Hower Kwon; Shuting Jin; Booil Jo; Stylianos E Antonarakis; Michael A Morris; Allan L Reiss
Journal:  Nat Neurosci       Date:  2005-10-23       Impact factor: 24.884

9.  Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study.

Authors:  Marie Schaer; Martin Debbané; Meritxell Bach Cuadra; Marie-Christine Ottet; Bronwyn Glaser; Jean-Philippe Thiran; Stephan Eliez
Journal:  Schizophr Res       Date:  2009-12       Impact factor: 4.939

Review 10.  Velo-cardio-facial syndrome: 30 Years of study.

Authors:  Robert J Shprintzen
Journal:  Dev Disabil Res Rev       Date:  2008
View more
  24 in total

Review 1.  Behavioral and Psychiatric Phenotypes in 22q11.2 Deletion Syndrome.

Authors:  Kerri L Tang; Kevin M Antshel; Wanda P Fremont; Wendy R Kates
Journal:  J Dev Behav Pediatr       Date:  2015-10       Impact factor: 2.225

2.  Working Memory Impairments in Chromosome 22q11.2 Deletion Syndrome: The Roles of Anxiety and Stress Physiology.

Authors:  Ashley F P Sanders; Diana A Hobbs; David D Stephenson; Robert D Laird; Elliott A Beaton
Journal:  J Autism Dev Disord       Date:  2017-04

3.  Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.

Authors:  Michael Didriksen; Kim Fejgin; Simon R O Nilsson; Michelle R Birknow; Hannah M Grayton; Peter H Larsen; Jes B Lauridsen; Vibeke Nielsen; Pau Celada; Noemi Santana; Pekka Kallunki; Kenneth V Christensen; Thomas M Werge; Tine B Stensbøl; Jan Egebjerg; Francois Gastambide; Francesc Artigas; Jesper F Bastlund; Jacob Nielsen
Journal:  J Psychiatry Neurosci       Date:  2017-01       Impact factor: 6.186

4.  Cognitive remediation for adolescents with 22q11 deletion syndrome (22q11DS): a preliminary study examining effectiveness, feasibility, and fidelity of a hybrid strategy, remote and computer-based intervention.

Authors:  Margaret A Mariano; Kerri Tang; Matthew Kurtz; Wendy R Kates
Journal:  Schizophr Res       Date:  2015-06-01       Impact factor: 4.939

5.  Childhood predictors of written expression in late adolescents with 22q11.2 deletion syndrome: a longitudinal study.

Authors:  N Hamsho; K M Antshel; T L Eckert; W R Kates
Journal:  J Intellect Disabil Res       Date:  2017-03-08

Review 6.  Intervention in the context of development: pathways toward new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Zachary Warren
Journal:  Neuropsychopharmacology       Date:  2014-09-03       Impact factor: 7.853

7.  Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.

Authors:  James J Yi; Sunny X Tang; Donna M McDonald-McGinn; Monica E Calkins; Daneen A Whinna; Margaret C Souders; Elaine H Zackai; Elizabeth Goldmuntz; James W Gaynor; Ruben C Gur; Beverly S Emanuel; Raquel E Gur
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-11-22       Impact factor: 3.568

8.  Childhood Executive Functioning Predicts Young Adult Outcomes in 22q11.2 Deletion Syndrome.

Authors:  Avery B Albert; Tamara Abu-Ramadan; Wendy R Kates; Wanda Fremont; Kevin M Antshel
Journal:  J Int Neuropsychol Soc       Date:  2018-10       Impact factor: 2.892

9.  A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.

Authors:  R E Gur; A S Bassett; D M McDonald-McGinn; C E Bearden; E Chow; B S Emanuel; M Owen; A Swillen; M Van den Bree; J Vermeesch; J A S Vorstman; S Warren; T Lehner; B Morrow
Journal:  Mol Psychiatry       Date:  2017-08-01       Impact factor: 15.992

10.  Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects.

Authors:  Yingjie Zhao; Tingwei Guo; Ania Fiksinski; Elemi Breetvelt; Donna M McDonald-McGinn; Terrence B Crowley; Alexander Diacou; Maude Schneider; Stephan Eliez; Ann Swillen; Jeroen Breckpot; Joris Vermeesch; Eva W C Chow; Doron Gothelf; Sasja Duijff; Rens Evers; Thérèse A van Amelsvoort; Marianne van den Bree; Michael Owen; Maria Niarchou; Carrie E Bearden; Claudia Ornstein; Maria Pontillo; Antonino Buzzanca; Stefano Vicari; Marco Armando; Kieran C Murphy; Clodagh Murphy; Sixto Garcia-Minaur; Nicole Philip; Linda Campbell; Jaume Morey-Cañellas; Jasna Raventos; Jordi Rosell; Damian Heine-Suner; Robert J Shprintzen; Raquel E Gur; Elaine Zackai; Beverly S Emanuel; Tao Wang; Wendy R Kates; Anne S Bassett; Jacob A S Vorstman; Bernice E Morrow
Journal:  Am J Med Genet A       Date:  2018-10-05       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.